Clinical Trial

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will consist of 2 parts: Part Ⅰ - Single Ascending Dose (SAD) study, Part Ⅱ - Food Effect (FE) study
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-15
notable Primary completion pushed: 2025-12 -> 2026-10 2026-08-15
minor Completion pushed: 2025-12 -> 2026-10 2026-08-15
Trial Details
NCT Number NCT06105151
Lead Sponsor Vigonvita Life Sciences
Conditions Schizophrenia
Enrollment 82 participants
Start Date 2023-10-27
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-14